2025 Regular Session
HB112
Provides relative to the prescribing, administering, and dispensing of drugs for off-label use
Partner positions
👍 3 cumulative active likes
Likes
Provides that no healthcare professional licensing board or commission shall prohibit or restrict the prescribing, administering, or dispensing for an off-label use of a human drug that has been approved for a specific use by the U.S. Food and Drug Administration (FDA).
This is an issue that arose during covid when the pharmacy board interrupted the prescription of meds.
No public reasoning provided.
Committee referrals
March 25, 2025 · House
Health and Welfare
Instrument history
i
This is the complete recorded action history in the current source package. Highlighted entries are marked as significant by the source. A roll-call link appears only when a vote-like action has one unambiguous same-day chamber vote.
-
House Read by title, under the rules, referred to the Committee on Health and Welfare.
-
House First appeared in the Interim Calendar on 3/28/2025.
-
House Under the rules, provisionally referred to the Committee on Health and Welfare.
-
House Prefiled.